Remission criteria for the follow-up of patients with acromegaly
dc.contributor.author | Gullu, S | |
dc.contributor.author | Keles, H | |
dc.contributor.author | Delibasi, T | |
dc.contributor.author | Tonyukuk, V | |
dc.contributor.author | Kamel, N | |
dc.contributor.author | Erdogan, G | |
dc.date.accessioned | 2020-06-25T17:40:09Z | |
dc.date.available | 2020-06-25T17:40:09Z | |
dc.date.issued | 2004 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description | Gedik, Vedia/0000-0003-0685-2020; | |
dc.description.abstract | Objective: The aim was to evaluate the validity of current remission criteria in acromegaly. a random GH level of < 2.5 mug/l, a glucose-suppressed GH level of < 1 mug/l and a normal IGF-I level. Design: In forty-one patients treated for acromegaly (23 males and 18 females, 20 - 69 years) and 94 healthy subjects (50 males and 44 females, 20-78 years), basal GH and IGF-I levels and nadir GH levels after 75 g oral glucose were evaluated in decade blocks; these were assayed by sensitive immunoradiometric assays. Results: Basal GH levels varied widely from 0.022 to 10.4 in healthy subjects and were > 2.5 mug/l in 19%. The mean post-glucose GH nadir was 0.067 +/- 0.009 mug/l (range 0.003-0.4 mug/l) and the upper limit of the GH nadir was 0.26 mug/l (means + 2 S.D.) in healthy subjects. Thirty-five patients with acromegaly had high-for-age IGF-I levels in relation to our healthy subjects. In this group, 15 (42.9%) patients had basal GH levels of < 2.5 mug/l, 14 (40%) patients had nadir GH levels of <1 mug/l, and three (8.6%) patients had GH suppression to < 0.26 mug/l which was defined as normal GH suppression in our healthy subjects. Only six patients with acromegaly had normal-forage IGF-I levels and all of these patients had basal GH levels of < 2.5 mug/l and all but one had nadir GH levels of < 0.26 mug/l. Conclusions: A basal or random GH level of < 2.5 mug/l is not a reliable criterion for remission in acromegaly and the currently accepted normal upper limit of 1 mug/l for post-glucose GH suppression is too high. Post-glucose nadir GH levels, measured with sensitive assays, can be < 1.0 mug/l in 40% and basal GH levels can be < 2.5 mug/l in 43% of the active acromegalic patients. IGF-I levels appeared to correlate better with a nadir GH cut-off of 0.26 mug/l rather than 1 mug/l in the determination of disease activity. | en_US |
dc.identifier.citation | Güllü, S., Keles, H., Delibasi, T., Tonyukuk, V., Kamel, N., & Erdogan, G. (2004). Remission criteria for the follow-up of patients with acromegaly. European journal of endocrinology, 150(4), 465–471. | en_US |
dc.identifier.doi | 10.1530/eje.0.1500465 | |
dc.identifier.endpage | 471 | en_US |
dc.identifier.issn | 0804-4643 | |
dc.identifier.issn | 1479-683X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 15080775 | |
dc.identifier.scopus | 2-s2.0-2342599685 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 465 | en_US |
dc.identifier.uri | https://doi.org/10.1530/eje.0.1500465 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/3311 | |
dc.identifier.volume | 150 | en_US |
dc.identifier.wos | WOS:000221195000009 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Bioscientifica Ltd | en_US |
dc.relation.ispartof | European Journal Of Endocrinology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Remission criteria for the follow-up of patients with acromegaly | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- Remission criteria for the follow-up of patients with acromegaly.pdf
- Boyut:
- 135.54 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text